Zhejiang WildWind Bio-Technology Co., Ltd. focuses on pharmaceuticals and biopharmaceuticals. Built on our group-owned production facilities, we specialize in R&D and customized production of innovative drugs products. We integrate high-quality domestic GMP and non-GMP manufacturing capacities to deliver one-stop CDMO and CMO services across lab-scale, pilot and commercial production stages, with rapid response capabilities for kilogram to ton-level scalable manufacturing.
As a wholly-owned subsidiary of Zhejiang WildWind Import & Export Co., Ltd., the company is part of WildWind Group. Backed by the Group’s strong industrial strength and integrated supply chain, we provide global clients with compliant, efficient and scalable pharmaceutical R&D and manufacturing solutions.
Core technology platefroms
Microbial Fermentation Technology Platform , Chiral Drug Technology Platform, Synthetic Biology Technology platform, Fluid Chemistry Technology Platform.
Types Of Chemical Reactions:
Cyanidation reaction, Esterification reaction
Resolution reaction , Diazotization reaction
Oxidation reaction.
Biogical enzymes and immobilization:
1. Alcohol oxidase (AOX)
2. w-Aminotransferase (ATA)
3. Lysyl Oxidase (LO)
4. Imine Reductase (IRED)
5. Ketoreductase(KRED)
6. Lyase
7. Acylase
9. Deacylase (EchDA): Synthesis of micafungin mother nucleus and anifulafungin nother nuclears
China
